Buprenorphine and Naloxone
NDC 62756-970, Buprenorphine and Naloxone, tablet, from Sun Pharmaceutical Industries, Inc..
- Product NDC
- 62756-970
- Status
- Listed
- Labeler
- Sun Pharmaceutical Industries, Inc.
- Dosage form
- TABLET
- Route
- SUBLINGUAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA201633
- DEA schedule
- CIII
curl https://api.healthcare.dev/v1/drugs/ndc/62756-970 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- BUPRENORPHINE HYDROCHLORIDE8 mg/1
- NALOXONE HYDROCHLORIDE DIHYDRATE2 mg/1
Pharmacologic classes
Opioid Antagonist [EPC]; Opioid Antagonists [MoA]; Partial Opioid Agonist [EPC]; Partial Opioid Agonists [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 62756-970-64 | 62756097064 | 3 BLISTER PACK in 1 CARTON (62756-970-64) / 10 TABLET in 1 BLISTER PACK |
| 62756-970-83 | 62756097083 | 30 TABLET in 1 BOTTLE (62756-970-83) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/91b68606-05de-4586-ae31-07e8cc9160cfNADAC price for package 62756097083
GET /v1/drugs/nadac/62756097083
Use it
Look up 62756-970 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/62756-970 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 62756-970. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.